...
首页> 外文期刊>Vaccine >Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine.
【24h】

Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine.

机译:针对百日咳的短期免疫,特定年龄的传播途径以及青少年加强疫苗的实用性。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Pertussis incidence has been increasing for the past two decades in Norway, as in much of the highly vaccinated world. The greatest increase is in teenagers, although the most severe cases occur in infants. A teenage booster is recommended globally, largely with the aim of reducing infant incidence. However few countries have implemented the booster, and almost no data have been published on its utility in preventing infant cases. We aim to assess the duration of vaccine-induced immunity, and the possibility for a teenage-booster vaccine to protect infants in Norway. METHODS AND FINDINGS: We used a unique data set that merged case reports with a national vaccine registry from Norway, 1996-2010, to assess age- and cohort-specific hazards of infection. We also developed and implemented a likelihood-based method for estimating the duration of immunity, taking into account age-contact data relevant for pertussis transmission. The risk of infection in thirteen-year olds increased nearly four-fold, however the hazard in infants did not significantly change. The seasonality of cases in pre-school-aged children differed from that of school-aged children. The introduction of a childhood booster vaccine provided indirect protection for unvaccinated members of the cohort, but little protection to neighboring cohorts. Additionally, we found evidence for increasingly rapid infection after three doses of vaccine, potentially caused by significant and heterogeneous loss of immunity. An estimated 15% of vaccinated individuals lost their immunity within five years after vaccination. CONCLUSIONS: Immunity induced by the acellular pertussis vaccine prevents both disease and transmission, but is short-lived and heterogeneous. The age-mixing patterns lead to little contact between teenagers and infants. Therefore, while a teenage booster vaccine campaign would likely provide strong protection for cohorts of teenagers, it would provide little protection for infants
机译:背景:在过去的二十年中,挪威的百日咳发病率一直在上升,在许多高度接种疫苗的世界中也是如此。增长最大的是青少年,尽管最严重的情况发生在婴儿中。在全球范围内推荐青少年助推器,主要目的是减少婴儿的发病率。但是,很少有国家实施该疫苗的使用,并且几乎没有关于其在预防婴儿病例中用途的数据。我们的目的是评估疫苗诱导的免疫力的持续时间,以及在挪威保护青少年婴儿疫苗的可能性。方法和研究结果:我们使用了独特的数据集,将病例报告与挪威国家疫苗注册中心(1996-2010年)合并,以评估特定年龄和人群的感染危害。我们还开发并实施了一种基于可能性的方法来估计免疫力的持续时间,同时考虑了与百日咳传播有关的年龄接触数据。 13岁儿童的感染风险增加了近四倍,但是婴儿的危害没有明显改变。学龄前儿童的病例季节性不同于学龄儿童。儿童增强疫苗的引入为未接种疫苗的队列成员提供了间接保护,但对邻近队列的保护很小。此外,我们发现了三剂疫苗后感染迅速增加的证据,这可能是由于免疫力的显着和异质性丧失引起的。估计有15%的疫苗接种者在接种疫苗后的五年内丧失了免疫力。结论:脱细胞百日咳疫苗诱导的免疫可以预防疾病和传播,但寿命短且异质。年龄混合模式导致青少年与婴儿之间的接触很少。因此,虽然青少年加强疫苗运动可能会为青少年群体提供强有力的保护,但对婴儿的保护却很少

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号